Skip to Content

Notice

Advisory Committee; Renewals

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing the Start Printed Page 15264renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed below for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed below. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).

DATES:

Authority for these committees will expire on the date indicated below unless the Commissioner formally determines that renewal is in the public interest.

Name of committeeDate of expiration
Anti-Infective Drugs Advisory CommitteeOctober 7, 2002
Dermatologic and Ophthalmic Drugs Advisory CommitteeOctober 7, 2002
Biological Response Modifiers Advisory CommitteeOctober 28, 2002
Technical Electronic Product Radiation Safety Standards CommitteeDecember 24, 2002
Start Further Info

FOR FURTHER INFORMATION CONTACT:

Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5496.

Start Signature

Dated: March 1, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

End Signature End Further Info End Preamble

[FR Doc. 01-6509 Filed 3-15-01; 8:45 am]

BILLING CODE 4160-01-F